Skip To Main Content
Elizabeth Orr on Muck Rack

Elizabeth Orr

Verified
Arlington
As seen in: Medtech Insight, Wiley Online Library, Taylor & Francis Online, Bristol University Press and Policy Press, Generics Bulletin, HBW Insight, In Vivo, The Pink Sheet, Citeline, UroToday, Hill Country Community Journal and
Managing editor of policy & regulation for @Medtech_Insight at @pharma_intell. Any opinions are my own; RTs do not equal endorsement.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Elizabeth

Contact Elizabeth, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Boston Scientific Halts Enroute TCAR Systems Over Arterial Sheath Issue

|
By Elizabeth Orr Verified
| Medtech Insight Verified
Boston Scientific is telling customers to stop using Enroute Transcarotid Neuroprotection System and Enroute Transcarotid Neuroprotection System Plus. The devices, which help prevent stroke during treatment of carotid artery disease, may come apart during use.
Open in Who Shared Issue with article?

CMS Coverage Decision Looms as Edwards Posts Strong Quarter, Eyes TAVR Expansion

|
By Elizabeth Orr Verified
| Medtech Insight Verified
Edwards Lifesciences beat Q2 expectations across all three segments, but the September CMS coverage decision on TAVR — expected to open access to asymptomatic patients — may define its near future. Edwards Lifesciences posted stronger-than-expected second-quarter results on July 23, driven by broad growth across its structural heart portfolio.
Open in Who Shared Issue with article?

FDA Invites Digital Health Industry To Apply For Grants Supporting Drug Development Research

|
By Elizabeth Orr Verified
| Medtech Insight Verified
The FDA is offering grants of up to $1.1m each to fund research into using digital health tools across the drug development pipeline. Medtech firms are among those eligible to apply, with the deadline Aug. 20. The FDA is taking applications for grants to fund research on use of digital health tools in drug development.
Open in Who Shared Issue with article?
See all 1,655 licensed articles (1,656 Total)